TOBRAMYCINE ZENTIVA 300 mg/5 ml, solution for inhalation by nebulizer 56 ampoules of 5 ml
Active ingredients: Tobramycin
Commercialized according to BDPMDispensing in France: Prescription only
Solution for inhalation by nebulizer56 ampoules of 5 mlinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TOBRAMYCINE ZENTIVA 300 mg/5 mL, solution pour inhalation par nébuliseur
- Pharmaceutical form
- solution pour inhalation par nébuliseur
- Route of administration
- inhalée
- Presentation description
- 56 ampoules unidoses polyéthylène basse densité (PEBD) surpochées de 5 mL
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Feb 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69472455CIP73017773CIP133400930177730Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TOBRAMYCINEsolution | 300 mg · une ampoule de 5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.